GlassScriptPhysician profile
Melissa C Lehmann
NPI 1609860634
$1,923.12
in general payments reported to CMS, 2019-2025
12 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $181 · 2022: $349 · 2023: $415 · 2024: $641 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.16 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $338.21 | 2022-2024 | |
| Abbott Laboratories | $320.76 | 2024-2025 | Freestyle Libre 3 |
| Inari Medical, INC. | $212.74 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbvie INC. | $168.57 | 2021-2023 | |
| Horizon Therapeutics Plc | $124.04 | 2023 | Uplizna |
| Mallinckrodt Hospital Products INC. | $122.28 | 2024 | Terlivaz |
| Mylan Specialty L.P. | $122.02 | 2024 | Yupelri |
| Daiichi Sankyo INC. | $120.02 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $118.54 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $116.63 | 2025 | |
| Gilead Sciences, INC. | $90.82 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Lehmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.